Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2003
08/20/2003EP1336606A1 6-Alkoxy-2,3-diaminopyridine couplers for dying keratin fibers
08/20/2003EP1336605A1 Substituted benzene derivatives or salts thereof
08/20/2003EP1335916A1 Pyridyl-substituted triazoles as tgf inhibitors
08/20/2003EP1335915A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
08/20/2003EP1335913A1 A process for the preparation of pantoprazole and intermediates therefor
08/20/2003EP1335912A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors
08/20/2003EP1335908A2 Peroxisome proliferator activated receptor alpha agonists
08/20/2003EP1335907A1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
08/20/2003EP1335906A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands
08/20/2003EP1335905A1 Hetero-anellated ortho-aminophenols and their use as dye components
08/20/2003EP1335901A1 Pharmaceutically active sulfanilide derivatives
08/20/2003EP1335722A2 Compounds useful in the treatment of cns disorders
08/20/2003EP1263504B1 Use of compounds with 5-ht1a activity useful for treating disorders of the outer retina
08/20/2003EP1165542B1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1053233B1 Hydroxamic and carboxylic acid derivatives
08/20/2003EP0934058B1 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
08/20/2003EP0923542B1 Aryl substituted cyclic amines as selective dopamine d3 ligands
08/20/2003EP0900083B1 Novel substituted imidazole compounds
08/20/2003CN1437595A Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
08/20/2003CN1437594A Substituted bicyclic derivatives for the treatment of abnormal cell growth
08/20/2003CN1437593A Novel amorphous form of omeprazole salts
08/20/2003CN1437592A Process for producing crystal
08/20/2003CN1437589A Process for the preparation of pyrazolopyrimidin ones
08/20/2003CN1437585A Method and compositions utilizing quinazolinones
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1437583A Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
08/20/2003CN1118476C Antiviral protease inhibitors
08/20/2003CN1118464C Novel pyrimidine derivatives and process producing the same
08/20/2003CN1118462C Substituted phenyl derivatives, producing method and use thereof
08/20/2003CN1118460C Pyrimidine derivatives as 5HT2C-receptor antagonists
08/20/2003CN1118459C Pyrimidinedione, pyrimidi netrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-adrenergic receptor antagonists
08/20/2003CN1118458C Pyrimidinyl derivatives as interleukin inhibitors
08/20/2003CN1118457C Cyclic diamine compound and medicine containing the same
08/20/2003CN1118456C 1,2-dihydro-2-oxoquinoline derivatives
08/20/2003CN1118454C Heterocyclic derivative and medicine
08/20/2003CN1118451C Acylated derivatives of melatonin and its analogues as medicine
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608204 Peptide aldehyde having arginine or arginine mimics at P1 and pyridone, pyrimidone, or uracil groups; antithrombosis agents
08/19/2003US6608203 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
08/19/2003US6608197 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
08/19/2003US6608104 Gem substituted hydroxamic acids
08/19/2003US6608095 Sulfonylbenzene and sulfonamidobenzene compounds which inhibit COX-2; treatment of a medical condition in which prostaglandins are implicated as pathogens
08/19/2003US6608092 Crystals of benzimidazole compounds
08/19/2003US6608086 Dihydropyridines and new uses thereof
08/19/2003US6608084 Treatment of human or non-human animal patient suffering from, or subject to, condition which can be ameliorated by administration of inhibitor of alpha 4 beta 1 mediated cell adhesion
08/19/2003US6608083 Treatment and/or prophylaxis of convulsive disorders, renal disorders, urinary incontinence, ocular inflammation, eating disorders, inflammatory pain, allergic rhinitis, psoriasis,neurodegenerative disorders, Huntington's disease,
08/19/2003US6608079 Activating serotonin-1F receptors, inhibiting neuronal protein extravasation, treating migraine
08/19/2003US6608071 Angiogenesis inhibitors as antitumor agents
08/19/2003US6608070 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens
08/19/2003US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents
08/19/2003US6608063 For example: (2-(3-amino-4-nitrophenyl)amino)ethyl)(6-(2,4-dichlorophenyl-5-nitropyrazin -2-yl)-amine; antidiabetic, -carcingenic and ischemic agents; nervous and cardiovascular system disorders; immunotherapy; obesity; syndromes
08/19/2003US6608060 Treating inflammatory diseases, destructive bone disorders, reperfusion/ischemia in stroke, myocardial ischemia, renal ischemia, cardiac hypertrophy, rheumatoid arthritis, inflammatory bowel disease, or Crohn's disease
08/19/2003US6608058 6-methylnicotinamide derivatives as antiviral agents
08/19/2003US6608052 Compounds useful as anti-inflammatory agents
08/19/2003US6608004 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones
08/19/2003US6607752 Forming a nicotine/cation exchange resin solvent mixture by blending nicotine, resin and solvent together, maintaining the solvnet in liquid state for a second by controlling pressure and temperature, then evaporation the solvent
08/19/2003US6607742 Suppository composition which is a spray-dried suspension of an acid-labile proton pump inhibitor in a solvent solution of a sterol and polymer
08/19/2003US6607741 Conjugates of sodium channel blockers and methods of using the same
08/19/2003CA2276324C Loratadine for use as an antiarrhythmic
08/19/2003CA2099867C 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
08/19/2003CA2079376C (bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/14/2003WO2003066889A2 Assay for acytyltransferase or deacetylase activity
08/14/2003WO2003066634A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
08/14/2003WO2003066629A2 Heteroaryl compounds useful as inhibitors of gsk-3
08/14/2003WO2003066624A1 Pyrimidinonesulfamoylureas as integrin ligands
08/14/2003WO2003066623A1 Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
08/14/2003WO2003066622A1 Novel benzimidazole compounds
08/14/2003WO2003066621A1 Piperidine derivatives and their use as antagonists of tachykinins
08/14/2003WO2003066613A1 N-phenyl-2-pyrimidine-amine derivatives
08/14/2003WO2003066607A1 Novel tetrazole derivative useful as herbicides
08/14/2003WO2003066604A2 Novel aryl- and heteroarylpiperazines
08/14/2003WO2003066599A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
08/14/2003WO2003066597A2 Guanidino compounds
08/14/2003WO2003066595A2 2 - piperazine - pyridines useful for treating pain
08/14/2003WO2003066593A2 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl )-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-methyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
08/14/2003WO2003066592A1 Gamma secretase inhibitors
08/14/2003WO2003066589A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
08/14/2003WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions
08/14/2003WO2003066099A1 2,4,6-triamino-1,3,5-triazine derivative
08/14/2003WO2003066059A1 Treatment of neuroblastoma
08/14/2003WO2003066057A1 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
08/14/2003WO2003066055A1 Quinoline derivatives as npy antagonists
08/14/2003WO2003066046A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2003066005A2 Ansamycins having improved pharmacological and biological properties
08/14/2003WO2003065991A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
08/14/2003WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
08/14/2003WO2003065983A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003WO2003053941A3 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
08/14/2003WO2003037335A8 5-heteroatom-substituted pyrazoles
08/14/2003WO2003024955A3 Small molecule inhibitors of caspases
08/14/2003WO2002064083A3 Synthesis of 3-amino-thalidomide and its enantiomers
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153766 Dissolving Lansoprazole hydrate in an organic solvent solution or suspension and crystalling and separating a Lansoprazole enantiomorph; resolution; purification; antiulcer agents
08/14/2003US20030153763 Indolinyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro isoquinolinyl, benz(cd)indolinyl and 5,6-dihydrophen anthridinyl compounds; treating neurodegenerative disorders
08/14/2003US20030153762 Process for preparing imidazoquinolinamines
08/14/2003US20030153761 Acid hydrolysis, condensation, cyclization and chlorination
08/14/2003US20030153754 Gamma-aminobutyric acid (gaba); anxiolytic agents, treating sleep and seizure disorders
08/14/2003US20030153751 Inhibitors of phospholipase enzymes
1 ... 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 ... 1080